<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02504528</url>
  </required_header>
  <id_info>
    <org_study_id>GIRD201534</org_study_id>
    <secondary_id>BAPT201534</secondary_id>
    <nct_id>NCT02504528</nct_id>
  </id_info>
  <brief_title>Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou</brief_title>
  <official_title>Bronchial Provocation Tests With House Dust Mite in Allergic Asthma in Guangzhou</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou Institute of Respiratory Disease</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Firestone Institute for Respiratory Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guangzhou Institute of Respiratory Disease</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish the methodology of bronchial provocation tests with
      house dust mites in China, and to evaluate its safety and effects on upper and lower airways
      inflammation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After screening,each participant undergo baseline lung function test,airway inflammation
      evaluation (blood and sputum eosinophils count,interleukin-13 (IL-13),FeNO)and airway
      responsiveness tests(methacholine bronchial provocation,nasal histamine provocation).

      On the second day,the participant undergo bronchial house dust mites challenge tests.

      On the third day,the participant undergo the lung function test,airway inflammation
      evaluation (blood and sputum eosinophils count,IL-13,FeNO)and airway responsiveness
      tests(methacholine bronchial provocation,nasal histamine provocation).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 1, 2015</start_date>
  <completion_date type="Actual">February 1, 2018</completion_date>
  <primary_completion_date type="Actual">July 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentages of the participants that tested positive to house dust mites bronchial provocation</measure>
    <time_frame>30 minutes after house dust mites bronchial provocation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of the percentages of eosinophils in sputum, nasal lavage and fractional exhaled nitric oxide (FeNO) from baseline</measure>
    <time_frame>30mins, 7 and 24 hours after bronchial challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of provocative concentration induced a 20% decrease in forced expiratory volume at one second (FEV1) to methacholine before and after house dust mites bronchial provocation</measure>
    <time_frame>24 hours after house dust mites bronchial challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentages of the participants that tested positive to house dust mites bronchial provocation measured by impulse oscillometry</measure>
    <time_frame>10 minutes after house dust mites bronchial provocation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of provocative concentration induced a 60% increase in nasal airway resistance to histamine before and after house dust mites bronchial provocation</measure>
    <time_frame>24 hours after house dust mites bronchial challenge</time_frame>
    <description>By Comparison with methacholine provocation test</description>
  </secondary_outcome>
  <other_outcome>
    <measure>correlate of IL-4,IL-13,periostin with provocative concentration induced a 20% decrease in FEV1 to house dust mite in asthmatic</measure>
    <time_frame>30 mins and 24 hours after house dust mites bronchial challenge</time_frame>
    <description>By Comparison with methacholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence and Severity of Adverse Events During The House Dust Mite Bronchial Provocation Test</measure>
    <time_frame>30 minutes, 7 hours and 24 hours after house dust mites bronchial provocation</time_frame>
    <description>By Comparison with methacholine provocation test at 30 min and 24 hours after challenge test.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Allergic Asthma</condition>
  <arm_group>
    <arm_group_label>allergic asthma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>asthma patients that sensitive to house dust mites.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>normal controls with or without sensitive to house dust mites.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>house dust mites</intervention_name>
    <description>house dust mites(two-fold increasing concentration of house dust mite (HDM) extract, dilutions prepared starting from 1:8, 1:16, 1:32, 1:64, 1:128, 1: 256, 1:512, 1:1024,……)</description>
    <arm_group_label>allergic asthma</arm_group_label>
    <arm_group_label>normal controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of asthma;

          -  Sensitive to house dust mite;

          -  Stable for more than 4 weeks with FEV1≥70%pred

        Exclusion Criteria:

          -  exacerbation within 3 months;

          -  upper airway infections within 6 weeks;

          -  concomitant of hypertension or heart diseases;

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jinping Zheng</last_name>
    <role>Principal Investigator</role>
    <affiliation>State Key Laboratory of Respiratory Disease; China Clinical Research Center of Respiratory Disease; First Affiliated Hospital of Guangzhou Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guangzhou institute of respiratory disease</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2015</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou Institute of Respiratory Disease</investigator_affiliation>
    <investigator_full_name>Jinping Zheng</investigator_full_name>
    <investigator_title>Deputy director,GRID</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>allergy</keyword>
  <keyword>bronchial hyperresponsiveness</keyword>
  <keyword>provocation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

